Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beads.

Mörtberg A, Meinke S, Berg P, Killie MK, Kjeldsen-Kragh J, Järås K, Refsum E, Höglund P, Wikman A.

J Immunol Methods. 2016 Jul;434:9-15. doi: 10.1016/j.jim.2016.04.001. Epub 2016 Apr 5.

PMID:
27059653
2.

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.

Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, Zdravic D, Vadasz B, Li C, Piran S, Marshall A, Zhu G, Tiller H, Killie MK, Boyd S, Leong-Poi H, Wen XY, Skogen B, Adamson SL, Freedman J, Ni H.

J Clin Invest. 2015 Apr;125(4):1545-56. doi: 10.1172/JCI77820. Epub 2015 Mar 16.

3.

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.

Kapur R, Kustiawan I, Vestrheim A, Koeleman CA, Visser R, Einarsdottir HK, Porcelijn L, Jackson D, Kumpel B, Deelder AM, Blank D, Skogen B, Killie MK, Michaelsen TE, de Haas M, Rispens T, van der Schoot CE, Wuhrer M, Vidarsson G.

Blood. 2014 Jan 23;123(4):471-80. doi: 10.1182/blood-2013-09-527978. Epub 2013 Nov 15.

4.

Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.

Husebekk A, El Ekiaby M, Gorgy G, Killie MK, Uhlin-Hansen C, Salma W, Navarrete C, El Afandi M, Skogen B, Ahlen MT.

Transfus Apher Sci. 2012 Dec;47(3):277-82. doi: 10.1016/j.transci.2012.04.001. Epub 2012 May 27.

PMID:
22640833
5.

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H.

Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17.

PMID:
22251227
6.

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.

Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2.

7.

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13.

PMID:
21895612
8.

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data.

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Blood. 2011 Sep 1;118(9):2638-9. doi: 10.1182/blood-2011-06-360404. No abstract available.

PMID:
21885616
9.

Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A.

Expert Rev Hematol. 2010 Oct;3(5):559-66. doi: 10.1586/ehm.10.49. Review.

PMID:
21083473
10.

Quantitative MAIPA: Comparison of different MAIPA protocols.

Killie MK, Salma W, Bertelsen E, Skogen B, Husebekk A.

Transfus Apher Sci. 2010 Oct;43(2):149-54. doi: 10.1016/j.transci.2010.07.001. Epub 2010 Aug 2.

PMID:
20675194
11.

Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.

Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J.

Scand J Immunol. 2009 Dec;70(6):531-4. doi: 10.1111/j.1365-3083.2009.02339.x. Review.

12.

Is it time to implement HPA-1 screening in pregnancy?

Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B.

Curr Opin Hematol. 2009 Nov;16(6):497-502. doi: 10.1097/MOH.0b013e3283317be9. Review.

PMID:
19730261
13.

Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme.

Tiller H, Killie MK, Skogen B, Øian P, Husebekk A.

BJOG. 2009 Mar;116(4):594-8. doi: 10.1111/j.1471-0528.2008.02068.x.

14.

The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand?

Bessos H, Killie MK, Seghatchian J, Skogen B, Urbaniak SJ.

Transfus Apher Sci. 2009 Apr;40(2):75-8. doi: 10.1016/j.transci.2009.01.010. Epub 2009 Feb 14.

PMID:
19223235
15.

In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies.

Kjeldsen-Kragh J, Kim M, Killie MK, Husebekk A, Freedman J, Semple JW.

Haematologica. 2009 Mar;94(3):441-3. doi: 10.3324/haematol.13827. Epub 2009 Jan 30. No abstract available.

16.

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.

Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB.

Blood. 2009 Apr 16;113(16):3838-44. doi: 10.1182/blood-2008-09-178475. Epub 2009 Jan 9.

PMID:
19136661
17.

Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).

Bessos H, Killie MK, Matviyenko M, Husebekk A, Urbaniak SJ.

Transfus Apher Sci. 2008 Dec;39(3):221-7. doi: 10.1016/j.transci.2008.09.006. Epub 2008 Oct 21.

PMID:
18945639
18.

What's happening--probing of HPA-1a antigen-antibody interaction by surface plasmon resonance technology.

Bessos H, Matviyenko M, Brown P, Husebekk A, Killie MK, Seghatchian J, Santoso S, Urbaniak SJ.

Transfus Apher Sci. 2008 Oct;39(2):179-82. doi: 10.1016/j.transci.2008.06.005.

PMID:
18710823
19.

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Transfus Apher Sci. 2008 Jun;38(3):183-8. doi: 10.1016/j.transci.2008.04.010. Epub 2008 May 21. Review.

PMID:
18499524
20.

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.

Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B.

Haematologica. 2008 Jun;93(6):870-7. doi: 10.3324/haematol.12515. Epub 2008 Apr 28.

21.

Management of alloimmune thrombocytopenia.

Kanhai HH, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, Goldman M, Bonacossa I, Richard L, David M, Taaning E, Hedegaard M, Kaplan C, Kiefel V, Meyer O, Salama A, Morelati F, Greppi N, Marconi M, Tassis B, Tsuno NH, Takahashi K, Oepkes D, Porcelijn L, Kanhai H, Osnes LT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Zupanska B, Muñiz-Diaz E, Nogués N, Parra J, Urbaniak SJ, Cameron A.

Vox Sang. 2007 Nov;93(4):370-85. No abstract available.

PMID:
18070283
22.

The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.

Valentin N, Gagne K, Kerdudou N, Hallé L, Kaplan C, Killie MK, Skogen B, Muller JY, Bignon JD.

Transfusion. 2007 Dec;47(12):2322-9. Epub 2007 Aug 21.

PMID:
17714418
23.

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Øian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A.

Blood. 2007 Aug 1;110(3):833-9. Epub 2007 Apr 11.

PMID:
17429009
24.

Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.

Killie MK, Kjeldsen-Kragh J, Husebekk A, Skogen B, Olsen JA, Kristiansen IS.

BJOG. 2007 May;114(5):588-95. Epub 2007 Mar 13. Erratum in: BJOG. 2007 Nov;114(11):1453.

25.

Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study.

Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B.

Transfusion. 2007 Jan;47(1):55-8.

PMID:
17207230
26.

[Three special cases of pregnancy outcome to reflect about].

Lindemann R, Svenningsen L, Kjeldsen-Kragh J, Stiris TA, Killie MK, Husebekk A.

Tidsskr Nor Laegeforen. 2004 Sep 9;124(17):2244-6. Norwegian.

PMID:
15457611
27.

Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women.

Killie MK, Kjeldsen-Kragh J, Randen I, Skogen B, Husebekk A.

Transfus Apher Sci. 2004 Apr;30(2):89-92.

PMID:
15062744
28.

Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo.

Busund LT, Killie MK, Bartnes K, Seljelid R.

Int J Cancer. 2003 Aug 20;106(2):153-9.

29.

Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis.

Randen I, Sørensen K, Killie MK, Kjeldsen-Kragh J.

Transfusion. 2003 Apr;43(4):445-50.

PMID:
12662276
30.
31.

Spontaneous hybridization of macrophages and Meth A sarcoma cells.

Busund LT, Killie MK, Bartnes K, Olsen R, Seljelid R.

Int J Cancer. 2002 Apr 1;98(4):573-81.

32.

Differential expression of major histocompatibility complex class II variants in cells infiltrating the meth A sarcoma.

Busund L, Killie MK, Leon F, Fandrem J, Bartnes K.

Scand J Immunol. 1999 May;49(5):501-5.

33.

Conjugates of Tremella polysaccharides with microbeads and their TNF-stimulating activity.

Gao Q, Berntzen G, Jiang R, Killie MK, Seljelid R.

Planta Med. 1998 Aug;64(6):551-4.

PMID:
9741303
34.

Characterization and cytokine-stimulating activities of acidic heteroglycans from Tremella fuciformis.

Gao Q, Killie MK, Chen H, Jiang R, Seljelid R.

Planta Med. 1997 Oct;63(5):457-60.

PMID:
9342951
35.

Cytokine-Stimulating (In Vitro) Effect on Human Monocytes of Conjugates of Soluble Curdlan and Albumin Microbeads.

Gao Q, Berntzen G, Killie MK, Seljelid R.

Drug Deliv. 1997;4(4):239-45. doi: 10.3109/10717549709052009.

PMID:
26582442

Supplemental Content

Loading ...
Support Center